Hunan Jiudian Pharmaceutical Co., Ltd.

SZSE:300705 Stock Report

Market Cap: CN¥11.2b

Hunan Jiudian Pharmaceutical Management

Management criteria checks 2/4

Hunan Jiudian Pharmaceutical's CEO is Yang Yang, appointed in Jan 2024, has a tenure of less than a year. directly owns 0.1% of the company’s shares, worth CN¥11.38M. The average tenure of the management team and the board of directors is 9.9 years and 9.9 years respectively.

Key information

Yang Yang

Chief executive officer

CN¥1.8m

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.1%
Management average tenure9.9yrs
Board average tenure9.9yrs

Recent management updates

Recent updates

We Think Hunan Jiudian Pharmaceutical (SZSE:300705) Can Stay On Top Of Its Debt

Nov 29
We Think Hunan Jiudian Pharmaceutical (SZSE:300705) Can Stay On Top Of Its Debt

Do Hunan Jiudian Pharmaceutical's (SZSE:300705) Earnings Warrant Your Attention?

Oct 22
Do Hunan Jiudian Pharmaceutical's (SZSE:300705) Earnings Warrant Your Attention?

With Hunan Jiudian Pharmaceutical Co., Ltd. (SZSE:300705) It Looks Like You'll Get What You Pay For

Aug 12
With Hunan Jiudian Pharmaceutical Co., Ltd. (SZSE:300705) It Looks Like You'll Get What You Pay For

Here's Why Hunan Jiudian Pharmaceutical (SZSE:300705) Can Manage Its Debt Responsibly

Jun 23
Here's Why Hunan Jiudian Pharmaceutical (SZSE:300705) Can Manage Its Debt Responsibly

Hunan Jiudian Pharmaceutical (SZSE:300705) Is Increasing Its Dividend To CN¥0.321

May 21
Hunan Jiudian Pharmaceutical (SZSE:300705) Is Increasing Its Dividend To CN¥0.321

Here's Why We Think Hunan Jiudian Pharmaceutical (SZSE:300705) Might Deserve Your Attention Today

Apr 12
Here's Why We Think Hunan Jiudian Pharmaceutical (SZSE:300705) Might Deserve Your Attention Today

Earnings Not Telling The Story For Hunan Jiudian Pharmaceutical Co., Ltd. (SZSE:300705) After Shares Rise 27%

Mar 04
Earnings Not Telling The Story For Hunan Jiudian Pharmaceutical Co., Ltd. (SZSE:300705) After Shares Rise 27%

CEO

Yang Yang (40 yo)

less than a year

Tenure

CN¥1,788,000

Compensation

Mr. Yang Yang is Non-Independent Director & General Manager of Hunan Jiudian Pharmaceutical Co., Ltd. from January 25, 2024. He joined the Hunan Jiudian Pharmaceutical Co., Ltd.in 2007. He was Deputy Gene...

Leadership Team

NamePositionTenureCompensationOwnership
Yang Yang
Non-Independent Director & GMless than a yearCN¥1.79m0.10%
CN¥ 11.4m
Ying Xiong
Financial Director9.9yrsCN¥976.20k0.15%
CN¥ 16.3m
Zhi Yun Zhu
Director of Supply & Directorno dataCN¥914.10k0.74%
CN¥ 82.7m
Lei Zeng
Deputy GM & Secretary of the Board3.9yrsCN¥658.40k0.029%
CN¥ 3.2m
Ying Liu
Deputy General Manager9.9yrsCN¥1.09m0.45%
CN¥ 49.9m
Guo Wang
Accounting Supervisorno datano datano data
Pengyun Fan
Deputy GM & Director9.9yrsno data0.011%
CN¥ 1.3m
Shang Lu
Employee Representative Supervisor & Director of Production Centerno datano data0.015%
CN¥ 1.7m

9.9yrs

Average Tenure

47yo

Average Age

Experienced Management: 300705's management team is seasoned and experienced (9.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yang Yang
Non-Independent Director & GMless than a yearCN¥1.79m0.10%
CN¥ 11.4m
Zhi Yun Zhu
Director of Supply & Director9.9yrsCN¥914.10k0.74%
CN¥ 82.7m
Pengyun Fan
Deputy GM & Directorless than a yearno data0.011%
CN¥ 1.3m
Shang Lu
Employee Representative Supervisor & Director of Production Center9.9yrsno data0.015%
CN¥ 1.7m
Zhi Hong Zhu
Chairman of the Board of Directors9.9yrsCN¥1.51m33.68%
CN¥ 3.8b
Bin Duan
Chairman of Supervisory Board9.9yrsno data0.096%
CN¥ 10.7m
Sheng Hua Liang
Supervisor9.9yrsno data0.022%
CN¥ 2.5m
Jing Xiang
Independent Directorno dataCN¥72.00kno data
Qiulin Yang
Independent Directorno dataCN¥72.00kno data
Cong Shan Zhou
Independent Director3.9yrsCN¥72.00kno data

9.9yrs

Average Tenure

48.5yo

Average Age

Experienced Board: 300705's board of directors are considered experienced (9.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 12:51
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hunan Jiudian Pharmaceutical Co., Ltd. is covered by 11 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hao WuChasing Securities
Yizheng YangChina International Capital Corporation Limited
Kai WangCitic Securities Co., Ltd.